We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Webinar

Enabling Biomarker Discovery and Screening With FirePlex® Multiplex Assays

On-Demand
Multiplex assays combine several target analytes in a single reaction volume, allowing multiple biomarkers to be measured simultaneously.
Online Event

The Landscape of Cancer Research 2022

On-Demand
Returning for a second year, this online event will provide researchers with a unique opportunity to hear about the advances taking place within cancer research. We will bring together a broad cross-section of experts to share their work in areas such as omics, immunology, drug discovery and cell science.
Webinar

Every Breath You Take: Predicting Inhaled Drug ADME Using Lung-on-a-Chip

On-Demand
The administration of drugs via inhalation into the lungs is superior to many other methods of delivery because our lungs provide a large surface area for absorption, access to the whole blood volume and comparatively little metabolic activity. Currently, there are limited in vitro models in which the absorption and permeability of drugs across the lung and into systemic circulation can be precisely measured.

In this webinar, Dr. Emily Richardson will describe novel lung-on-a-chip (LOAC), otherwise known as lung microphysiolological system, models of the alveoli and bronchi which can be used to accurately predict drug pharmacokinetics, allowing for more rapid, precise and cost-effective analysis of compounds.

Webinar

Mapping the Future of Psychedelics: Deconstructing Powerful Drugs To Make Better Medicine

On-Demand
Join us on June 22 with Boris Heifets, MD, PhD, Assistant Professor of the Department of Anesthesiology, Perioperative and Pain Medicine at Stanford University School of Medicine, who will explore the future of psychedelic medicine.
Webinar

Identifying Novel Therapeutic Approaches and Predictive Biomarkers for Castleman Disease

On-Demand
No targeted therapies currently exist for this disease, and the only drug approved by the US Food and Drug Administration is effective in just one third of patients.
Webinar

Genomic Tools for Psilocybe cubensis Propagation

On-Demand
Kevin McKernan, CSO at Medicinal Genomics will be joining us to discuss genetic variation in the Psilocybe cubensis synthesis pathway and the design of qPCR assays for simultaneous quantification of E. coli and Salmonella species contamination concurrent with Psilocybe cubensis species identification.
Advertisement